Nova Mentis Life Science Stock Company Profile

Description

Nova Mentis Life Science Corp., through its subsidiaries, engages in the research and development of medicinal psychedelics for neuroinflammatory conditions with a focus on autism spectrum disorder in Canada. It is also involved in the research and development of psychedelic medicines for metabolic indications, such as obesity and diabetes; and development of cannabis products. Nova Mentis Life Science Corp. has a research agreement with the University of Central Florida (UCF) to develop a saliva serotonin assay. The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada.